已發(fā)表的部分文獻(xiàn): 標(biāo)題:Determinants for efficient editing with Cas9-mediated recombineering in Escherichia coli.作者:Choudhury A, Fankhauser RG, Freed EF, Oh EJ, Morgenthaler AB, Bassalo M, Copley SD, Kaar JL, Gill RT;雜志名稱(chēng):ACS Synth Biol 標(biāo)題:Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR/Cas9 into target cells作者:Baron, Y. et. al.;雜志名稱(chēng):Molecular Therapy: Nucleic Acid 標(biāo)題:[Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells].作者:Wang Y, Xie Y, Dong ZC, Jiang XJ, Gong P, Lu J, Wan F;雜志名稱(chēng):Mol Biol (Mosk) 標(biāo)題:A Scalable High-Throughput Isoelectric Fractionation Platform for Extracellular Nanocarriers: Comprehensive and Bias-Free Isolation of Ribonucleoproteins from Plasma, Urine, and Saliva.作者:Sharma H, Yadav V, D'Souza-Schorey C, Go DB, Senapati S, Chang HC;雜志名稱(chēng):ACS Nano Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開(kāi)發(fā)供應(yīng)商。開(kāi)發(fā)了超過(guò)700多個(gè)專(zhuān)利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。